Surgery Partners (SGRY) Stock: Buy, Sell, or Hold?
SGRY - Surgery Partners, Inc. Common Stock
$13.25
0.01 (0.11%)
▲
5d:
-8.02%
30d:
-5.26%
90d:
-22.09%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When SGRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SGRY shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SGRY shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.52
Based on -8.0% avg growth
INTRINSIC VALUE TODAY
$2.80
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SGRY is currently trading at $13.24, which is considered oversold relative to its 30-day fair value range of $13.58 to $14.57. From a valuation perspective, the stock is trading at a premium (Forward PE: 47.2) compared to its historical average (25.9). At these levels, the market is pricing in 22.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SGRY is showing sideways momentum. The price is currently testing key support at $12.97. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.82 (+42.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SGRY is showing sideways momentum. The price is currently testing key support at $12.97. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $18.82 (+42.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$13.58 -
$14.57
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.6%
Protect Your Profits
Holding SGRY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.2% below Wall St target ($18.82)
- NEUTRAL: Trading at premium valuation - market expects 22.2% growth which is achievable
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$13.58 -
$14.57
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$12.97
Resistance Level
$15.90
Current Trend
Sideways
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
47.25
Wall Street Target
$18.82
(+42.2%)
Revenue Growth (YoY)
2.7%
Profit Margin
-2.6%
Valuation Premium vs History
+22.2% premium
PE vs Historical
47.3 vs 25.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+22.2%
(market-implied from PE analysis)
1-Year Target
$16.17
(+22%)
2-Year Target
$19.76
(+49%)
3-Year Target
$24.14
(+83%)
3-Yr Target (if PE normalizes)
(PE: 47→26)
PE COMPRESSION
$13.23
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 47.2, Growth: -20.0%)
$9.64
(+-27%)
Base:
(SPY PE: 20.4, Growth: -20.0%)
$4.16
(-69%)
Bear:
(PE: 17.3, Growth: -20.0%)
$3.54
(-73%)
Share & Embed Analysis
Last updated: October 02, 2026 1:14 PM ET
Data refreshes hourly during market hours. Next update: 2:14 PM
Data refreshes hourly during market hours. Next update: 2:14 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 48 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$134 | 67 BUY |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 62 BUY |
Advanced SGRY Option Strategies
Professional options setups generated by AI based on today's SGRY price and gamma walls.
